Programa de detección de fallas de calidad en los medicamentos comercializados
Abstract
Defective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a center or service organized for that purpose within the framework of a national drug surveillance system
Translated title
A program to detect defective drugs in the postmarketing period
Subject
URI
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=isohttps://iris.paho.org/handle/10665.2/8897
Citation
(1999) Programa de detección de fallas de calidad en los medicamentos comercializados. Rev Panam Salud Publica;6(3) -,sept. 1999. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=iso